Nick focuses his practice on representing corporate issuers and borrowers, and financial institutions, lenders and other parties, in public and private offerings of securities, loan transactions and other financing transactions. He also represents companies in mergers and acquisitions and regularly advises clients in connection with public disclosure and corporate matters. Additionally, Mr. Dorsey dedicates a significant portion of his practice to providing commercial and strategic advice to startup, early stage and founder led companies and investors in such companies. Clients regularly seek his counsel for the practical, commercial advice he offers with respect to their most challenging matters. Nick has significant experience advising on IPOs, direct listings, SPAC combinations and spin-offs for companies such as Alliant Techsystems (ATK), Cano Health, Climate Transition Capital Acquisition I, Costamare, DRI Healthcare Trust, On, Palantir, SciPlay, Swvl, Vaxxinity and Vista Outdoor.

Nick is a frequent speaker and author on a range of finance topics. Nick has been recognized for his work in capital markets by Chambers USA, Chambers Global, The Legal 500 US and IFLR1000. He has been named to Bloomberg Law’s “40 Under 40” list and was named the “Equity Capital Markets Lawyer of the Year” by IFLR1000 in its United States Awards and a “Rising Star” by Law360, recognizing him as one of five outstanding capital markets lawyers in the nation under the age of 40.

For additional information, please visit: http://www.cravath.com/ndorsey